IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bigger, J. E.
Right arrow Articles by Atherton, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bigger, J. E.
Right arrow Articles by Atherton, S. S.
(Investigative Ophthalmology and Visual Science. 1999;40:2608-2613.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Protection against Murine Cytomegalovirus Retinitis by Adoptive Transfer of Virus-Specific CD8+ T Cells

John E. Bigger1, Minoru Tanigawa2, Charles A. Thomas, III1 and Sally S. Atherton1,2

From the Departments of 1 Microbiology and 2 Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio.

PURPOSE. Human cytomegalovirus retinitis, the most common ophthalmic infection of AIDS patients, has been modeled in BALB/c mice infected with murine cytomegalovirus by the supraciliary route. A series of depletion and adoptive transfer studies was performed to determine whether adoptive transfer of T cells protects mice from retinitis caused by murine cytomegalovirus infection after supraciliary inoculation and to determine which subset of T cells is responsible for protection.

METHODS. BALB/c mice were thymectomized and T cell–depleted by injection of monoclonal antibodies to CD4, CD8, or both. Murine cytomegalovirus (9 x 102 plaque forming units [pfu]) was injected into the supraciliary space. Experimental animals received murine cytomegalovirus-specific T cells or subsets of T cells 2 hours before virus injection, whereas control animals received herpes simplex virus type 1–specific T cells by tail vein injection. Eight days after virus injection, retinal pathology was scored by histopathologic examination of hematoxylin and eosin–stained ocular sections.

RESULTS. CD8+ T cell depletion was sufficient for development of retinitis after supraciliary injection of murine cytomegalovirus. Adoptive transfer of murine cytomegalovirus-specific T cells, but not herpes simplex virus type 1–specific T cells, provided protection from retinitis. Additionally, separation of the murine cytomegalovirus-specific T cells into CD8+ and CD4+ subsets before adoptive transfer showed that the CD8+ fraction of the adoptive T cells was responsible for protection.

CONCLUSIONS. These results suggest that adoptive transfer of cytomegalovirus-specific T cells or T cell subsets might be used to treat or prevent cytomegalovirus retinitis in immunosuppressed human patients.




This article has been cited by other articles:


Home page
J. Virol.Home page
S. Camelo, J. Castellanos, M. Lafage, and M. Lafon
Rabies Virus Ocular Disease: T-Cell-Dependent Protection Is under the Control of Signaling by the p55 Tumor Necrosis Factor Alpha Receptor, p55TNFR
J. Virol., April 1, 2001; 75(7): 3427 - 3434.
[Abstract] [Full Text]


Home page
CVIHome page
M. C.-J. Cheeran, G. Gekker, S. Hu, S. L. Yager, P. K. Peterson, and J. R. Lokensgard
CD4+ Lymphocyte-Mediated Suppression of Cytomegalovirus Expression in Human Astrocytes
Clin. Vaccine Immunol., July 1, 2000; 7(4): 710 - 713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology